Back

STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activity

Patel, B.; Zhou, Y.; Babcock, R. L.; Ma, F.; Zal, M. A.; Kumar, D.; Medik, Y. B.; Kahn, L. M.; Pineda, J. E.; Park, E. M.; Tang, X.; Raso, M. G.; Zal, T.; Clise-Dwyer, K.; Giancotti, F. G.; Colla, S.; Watowich, S. S.

2023-02-11 immunology
10.1101/2023.02.10.528069 bioRxiv
Show abstract

STAT3 function in hematopoietic stem and progenitor cells (HSPCs) has been difficult to discern as Stat3 deficiency in the hematopoietic system induces systemic inflammation, which can impact HSPC activity. To address this, we established mixed bone marrow (BM) chimeric mice with CreER-mediated Stat3 deletion in 20% of the hematopoietic compartment. Stat3-deficient HSPCs had impaired hematopoietic activity and failed to undergo expansion in BM in contrast to Stat3-sufficient (CreER) controls. Single-cell RNA sequencing of Lin-ckit+Sca1+ BM cells revealed altered transcriptional responses in Stat3-deficient hematopoietic stem cells (HSCs) and multipotent progenitors, including intrinsic activation of cell cycle, stress response, and interferon signaling pathways. Consistent with their deregulation, Stat3-deficient Lin-ckit+Sca1+ cells accumulated {gamma}H2AX over time. Following secondary BM transplantation, Stat3-deficient HSPCs failed to reconstitute peripheral blood effectively, indicating a severe functional defect in the HSC compartment. Our results reveal essential roles for STAT3 in HSCs and suggest the potential for using targeted synthetic lethal approaches with STAT3 inhibition to remove defective or diseased HSPCs. Key PointsO_LISTAT3 is critical for hematopoietic activity and hematopoietic stem cell maintenance in non-inflammatory conditions C_LIO_LISTAT3 has a cell-intrinsic role in the suppression of interferon signaling and myeloid-skewed transcription in hematopoietic stem cells C_LI

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Experimental Hematology
11 papers in training set
Top 0.1%
22.9%
2
Blood Advances
54 papers in training set
Top 0.1%
18.9%
3
Blood
67 papers in training set
Top 0.3%
6.4%
4
PLOS ONE
4510 papers in training set
Top 43%
2.9%
50% of probability mass above
5
The Journal of Immunology
146 papers in training set
Top 0.5%
2.8%
6
Cytotherapy
14 papers in training set
Top 0.1%
2.6%
7
Frontiers in Genetics
197 papers in training set
Top 3%
2.4%
8
Stem Cell Reports
118 papers in training set
Top 0.3%
2.1%
9
Leukemia
39 papers in training set
Top 0.4%
2.1%
10
eLife
5422 papers in training set
Top 35%
2.1%
11
Journal of Leukocyte Biology
40 papers in training set
Top 0.2%
1.9%
12
Journal of Experimental Medicine
106 papers in training set
Top 2%
1.7%
13
Scientific Reports
3102 papers in training set
Top 57%
1.7%
14
Immunology & Cell Biology
11 papers in training set
Top 0.1%
1.7%
15
Cell Reports
1338 papers in training set
Top 23%
1.7%
16
Frontiers in Immunology
586 papers in training set
Top 5%
1.5%
17
JCI Insight
241 papers in training set
Top 5%
1.2%
18
Haematologica
24 papers in training set
Top 0.3%
1.2%
19
Nature Communications
4913 papers in training set
Top 57%
1.1%
20
G3 Genes|Genomes|Genetics
351 papers in training set
Top 2%
0.9%
21
Frontiers in Physiology
93 papers in training set
Top 5%
0.9%
22
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.8%
23
International Journal of Molecular Sciences
453 papers in training set
Top 17%
0.7%
24
The Journal of Infectious Diseases
182 papers in training set
Top 6%
0.7%
25
PLOS Pathogens
721 papers in training set
Top 10%
0.5%
26
iScience
1063 papers in training set
Top 40%
0.5%
27
Stem Cell Research & Therapy
30 papers in training set
Top 1%
0.5%
28
Gene
41 papers in training set
Top 3%
0.5%
29
EMBO reports
136 papers in training set
Top 8%
0.5%